Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.

Institutional InvestorSimilar funds →SEC EDGAR: CIK 2011081
Institutional-grade research for retail investors

13F Reported Value

$1.2B

Holdings

51

Latest Filing

2026-03-31

Filing Quarter

Q1 2026

Portfolio Overview

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. disclosed 51 positions worth $1.2B in its Form 13F-HR for Q1 2026, led by $GOOGL (Alphabet Inc.) at 9.3% of the equity portfolio, followed by $MU and $ABVX. During the quarter the fund opened 7 new positions and exited 5 — including a new stake in $RVMD and a full exit from $AXSM. The portfolio is most concentrated in Technology (45.7% of disclosed assets). All figures are sourced directly from Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.’s Form 13F-HR filing with the SEC under CIK 2011081.

Sector Allocation

TechnologyHealthcareMaterialsConsumer DiscretionaryEnergyUtilities

AUM History

Top Equity Holdings by Value

Quarterly Activity — Q1 2026

Click any card to unlock

Top Holdings

AI Quality Scored

Unlock AI quality scores for every holding

32-signal composite ranking on each of Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s 51 positions.

Showing top 10 of 51 holdings.

Sector Allocation

Technology

$539.0M

Healthcare

$261.1M

Materials

$150.4M

Consumer Discretionary

$95.9M

Energy

$71.2M

Utilities

$49.8M

Industrials

$5.5M

Financials

$4.2M

Full Holdings — Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. (Q1 2026)

All 51 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.

#TickerCompanyValueWeightQoQQuality
1GOOGL$GOOGLAlphabet Inc.$110.2M9.3%-11%80.2
2MU$MUMICRON TECHNOLOGY INC$86.5M7.3%+6%88.4
3ABVX$ABVXAbivax S.A.$85.3M7.2%+11%
4PTGX$PTGXProtagonist Therapeutics, Inc$60.3M5.1%+0%24.8
5NVDA$NVDANVIDIA CORP$59.4M5.0%+5%90.2
6AMZN$AMZNAMAZON COM INC$54.8M4.6%-28%74.6
7RVMD$RVMDRevolution Medicines, Inc.$46.6M4.0%NEW
8CYTK$CYTKCYTOKINETICS INC$43.5M3.7%-12%28
9MSFT$MSFTMICROSOFT CORP$42.4M3.6%+22%83.7
10CRWD$CRWDCrowdStrike Holdings, Inc.$41.1M3.5%+49%55
11AVGO$AVGOBroadcom Inc.$39.8M3.4%+21%86.4
12DOW$DOWDOW INC.$39.5M3.4%NEW38
13LYB$LYBLyondellBasell Industries N.V.$39.0M3.3%NEW
14MELI$MELIMERCADOLIBRE INC$37.5M3.2%+248%77.5
15XOM$XOMEXXON MOBIL CORP$36.1M3.1%NEW61.8
16CVX$CVXCHEVRON CORP$35.1M3.0%NEW54.7
17LIN$LINLINDE PLC$33.4M2.8%+5%
18FCX$FCXFREEPORT-MCMORAN INC$32.6M2.8%+0%73.1
19AMAT$AMATAPPLIED MATERIALS INC /DE$29.0M2.5%+10%74.8
20CEG$CEGConstellation Energy Corp$28.5M2.4%NEW62.5
21VRT$VRTVertiv Holdings Co$26.4M2.2%-42%82.7
22WDC$WDCWESTERN DIGITAL CORP$26.2M2.2%-57%76.8
23WM$WMWASTE MANAGEMENT INC$21.3M1.8%-7%70.7
24GOOG$GOOGAlphabet Inc.$17.0M1.4%NEW80.2
25META$METAMeta Platforms, Inc.$14.9M1.3%+21%80.9
26INTC$INTCINTEL CORP$12.8M1.1%+0%41.5
27NKTR$NKTRNEKTAR THERAPEUTICS$8.8M0.8%-35%10.2
28QURE$QUREuniQure N.V.$8.5M0.7%+0%
29MRVL$MRVLMarvell Technology, Inc.$8.4M0.7%+0%77.3
30AMD$AMDADVANCED MICRO DEVICES INC$7.5M0.6%-28%78.8
31AAPL$AAPLApple Inc.$7.4M0.6%+139%76.1
32GEV$GEVGE Vernova Inc.$6.3M0.5%+109%70.1
33SCCO$SCCOSOUTHERN COPPER CORP/$5.8M0.5%+1%86.6
34JANX$JANXJanux Therapeutics, Inc.$5.2M0.4%+0%24.8
35WMT$WMTWalmart Inc.$3.6M0.3%+0%63.2
36MLYS$MLYSMineralys Therapeutics, Inc.$2.8M0.2%-84%
37CAT$CATCATERPILLAR INC$2.2M0.2%-54%67.8
38GE$GEGENERAL ELECTRIC CO$2.1M0.2%-46%74.8
39BRK.B$BRK.BBERKSHIRE HATHAWAY INC$1.9M0.2%-57%64.5
40CRM$CRMSalesforce, Inc.$1.7M0.1%+0%75.2
41RTX$RTXRTX Corp$1.7M0.1%-60%70
42FISV$FISVFISERV INC$1.6M0.1%+0%67.4
43GS$GSGOLDMAN SACHS GROUP INC$1.1M0.1%NEW
44NFLX$NFLXNETFLIX INC$599,0150.1%+0%86.7
45PG$PGPROCTER & GAMBLE Co$597,9820.1%+0%72.9
46JPM$JPMJPMORGAN CHASE & CO$532,7240.1%-90%35.6
47PEP$PEPPEPSICO INC$488,0760.0%+0%62.7
48KO$KOCOCA COLA CO$396,8290.0%+0%74
49BAC$BACBANK OF AMERICA CORP /DE/$366,6980.0%-85%68.4
50WFC$WFCWELLS FARGO & COMPANY/MN$226,5700.0%-95%
51SNOW$SNOWSnowflake Inc.$8,4460.0%-100%49.6

New Positions (7)

RVMD$RVMD Revolution Medicines, Inc.$46.6M
DOW$DOW DOW INC.$39.5M
LYB$LYB LyondellBasell Industries N.V.$39.0M
XOM$XOM EXXON MOBIL CORP$36.1M
CVX$CVX CHEVRON CORP$35.1M
CEG$CEG Constellation Energy Corp$28.5M
GS$GS GOLDMAN SACHS GROUP INC$1.1M

Exited Positions (5)

AXSM$AXSM Axsome Therapeutics, Inc.
SRRK$SRRK Scholar Rock Holding Corp
VRDN$VRDN Viridian Therapeutics, Inc.\DE
ORCL$ORCL ORACLE CORP
V$V VISA INC.

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

Available Analysis

13F Pro tracks comprehensive institutional data for Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. including:

Full 13F portfolio with all holdings
Quarter-over-quarter position changes
Accumulation & distribution patterns
Sector allocation breakdown
Historical portfolio evolution
New positions & complete exits
Concentration analysis
Peer comparison with similar funds
AI-powered portfolio insights

Track Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s Full Portfolio

See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. and 8,700+ other institutional investors.

View Pricing

Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

AI-Powered Hedge Fund Analysis: Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.

13F Pro is an AI hedge fund tracker and stock research platform. For Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. (SEC CIK: 2011081), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.